Clinical Trials Directory

Trials / Completed

CompletedNCT05184348

Plexin B2 Gene Expression and Polymorphisms in Psoriasis

Plexin B2 Gene Expression and Polymorphisms in Psoriasis : Relation to NB-UVB, Acitretin and Combined Therapy

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
200 (actual)
Sponsor
South Valley University · Academic / Other
Sex
All
Age
24 Years – 64 Years
Healthy volunteers
Accepted

Summary

Patients will be randomly assigned (1:1:1 ) either to ; NB-UVB photo-therapy alone , Acitretin therapy alone or NB-UVB photo-therapy combined with Acitretin therapy randomization will be done by closed envelopes . investigator will be blinded to study drug assignment , while patients and data interpreter will not be masked to study drug assignment.

Detailed description

Study Setting: Qena University Hospital, Department of Dermatology ,Venereology\& Andrology. Study subjects: the study will include psoriasis Vulgaris patients who Come to the out patients dermatologic clinic and matching inclusion \& exclusion criteria as follow, from 9/2021 up to 3/2023 and then patients will be divided to each group equally as follow: Group 1: Patients will be treated with NB-UVB phototherapy 3 sessions weekly for 3 months with maximum dose of 1400 mJ/cm2. Group 2: Patients will be treated with Acitretin in dose of 0.5-1 mg per kg per day orally for 3 months Group 3: Patients will be treated with Acitretin in dose of 0.5-1 mg per kg per day orally plus NB-UVB phototherapy 3 sessions weekly for 3 months with maximum dose 1400 mJ/cm2. Group 4: 30 healthy individuals un related , age, sex , BMI matched with volunteers.

Conditions

Interventions

TypeNameDescription
RADIATIONNarrow band Ultraviolet B phototherapy group3 sessions weekly for 3 months with maximum dose 1400 mJ/cm2.
DRUGAcitretin groupdose of 0.5-1 mg per kg per day orally for 3 month.
COMBINATION_PRODUCTAcitretin plus Narrow band Ultraviolet B phototherapy groupAcitretin in dose of 0.5-1 mg per kg per day orally plus Narrow band Ultraviolet B phototherapy 3 sessions weekly for 3 months with maximum dose 1400 mJ/cm2.

Timeline

Start date
2021-09-01
Primary completion
2023-01-30
Completion
2023-03-30
First posted
2022-01-11
Last updated
2023-09-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05184348. Inclusion in this directory is not an endorsement.